Page 37 - CIBEREHD-2015-eng

Research Groups
Most relevant scientific articles
reVerTer e., mesonero f., seiJo s., marTínez J., aBral- des J.G., Penas B. eT al. Effects of sapropterin on portal and systemic hemodynamics in patients with cirrhosis and portal hypertension: A bicentric double-blind place- bo-controlled study. American Journal of Gastroenterolo- gy. 2015;110(7):985-992.
alBillos a, marTínez J, Téllez l. Continued controversy over the safety of beta-blockers in decompensated cirrho- sis.Hepatology (Baltimore, Md.). 2015.
Cerini f., González J.m., Torres f., PuenTe a., Casas m., Vinaixa C. eT al. Impact of anticoagulation on upper-gas- trointestinal bleeding in cirrhosis. A retrospective multi- center study. Hepatology. 2015;62(2):575-583.
Thiele m., alBillos a., aBazi r., wiesT r., Gluud l.l., kraG a.. Non-selective beta-blockers may reduce risk of hepato- cellular carcinoma: A meta-analysis of randomized trials. Liver International. 2015;35(8):2009-2016.
lens s., rinCon d., GarCía-reTorTillo m., alBillos a., CalleJa J.l., Banares r. eT al. Association Between Se- vere Portal Hypertension and Risk of Liver Decompensa- tion in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy. Clinical Gastroenterology and Hepa- tology. 2015;13(10):1846-1853.
Highlights
Involvement of the group in the following projects:
1) The European Commission “Carbalive project” to study the use of carbons for the treatment of cir- rhosis and NASH,
2) VI Baveno Consensus Conference on Portal Hy- pertension, and
3) the Scientific Board of the Spanish Hepatitis C Action Plan.
Institution: Universidad de Alcalá · Contact: Facultad de Medicina. Campus Universitario Ctra. Madrid-Barcelona, km. 33,600. 28871 Alcalá de Henares · E.mail: [email protected]
CIBEREHD I Annual report 2015 I 37